A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Sarcoma · Myxofibrosarcoma · Undifferentiated Pleomorphic Sarcoma · Alveolar Soft Part Sarcoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448
  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448
  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Edmund Bartlett, MD) · 212-639-2448
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448
מובילי המחקר
  • Edmund Bartlett, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center